Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel B Roth

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
BMC Ophthalmology|April 18, 2015
Two or more dexamethasone intravitreal implants as monotherapy or in combination therapy for macular edema in retinal vein occlusion: subgroup analysis of a retrospective chart review studyMichael A Singer, Antonio Capone, Pravin U Dugel, et al.
Ophthalmology|June 7, 2011
The 1-year results of CLEAR-IT 2, a phase 2 study of vascular endothelial growth factor trap-eye dosed as-needed after 12-week fixed dosingJeffrey S Heier, David Boyer, Quan Dong Nguyen, et al.
The British Journal of Ophthalmology|December 15, 2015
Vitrectomy After ocriplasmin for VitreOmacular adhesion Or Macular hole (VAVOOM) studyMargaret A Greven, Sunir Garg, Bing Chiu, et al.
Ophthalmology|May 28, 2013
Incidence of choroidal neovascularization in the fellow eye in the comparison of age-related macular degeneration treatments trialsMaureen G Maguire, Ebenezer Daniel, Ankoor R Shah, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
BMC Ophthalmology|April 18, 2015
Two or more dexamethasone intravitreal implants as monotherapy or in combination therapy for macular edema in retinal vein occlusion: subgroup analysis of a retrospective chart review studyMichael A Singer, Antonio Capone, Pravin U Dugel, et al.
Ophthalmology|June 7, 2011
The 1-year results of CLEAR-IT 2, a phase 2 study of vascular endothelial growth factor trap-eye dosed as-needed after 12-week fixed dosingJeffrey S Heier, David Boyer, Quan Dong Nguyen, et al.
The British Journal of Ophthalmology|December 15, 2015
Vitrectomy After ocriplasmin for VitreOmacular adhesion Or Macular hole (VAVOOM) studyMargaret A Greven, Sunir Garg, Bing Chiu, et al.
Ophthalmology|May 28, 2013
Incidence of choroidal neovascularization in the fellow eye in the comparison of age-related macular degeneration treatments trialsMaureen G Maguire, Ebenezer Daniel, Ankoor R Shah, et al.
Pageof 5